Navigation Links
Nectid Announces Initiation Of Clinical Development Of Autism And Pain Drugs
Date:8/16/2012

PRINCETON, N.J., Aug. 16, 2012 /PRNewswire/ -- Nectid, Inc. (www.nectid.com), a Princeton based pharmaceutical product development company focused on discovering and developing novel drugs, announced initiating clinical development of agomelatine for autism and pain indications in the United States.

Agomelatine is a melatonergic agonist (MT1 and MT2 receptors) and 5-HT2C antagonist and is approved for the treatment of major depressive disorder in Europe, Australia and in several countries. Agomelatine has been reported to resynchronize circadian rhythms to restore sleep cycle. Circadian rhythm is believed to be involved in several disorders such as neuropathic pain, fibromyalgia, inflammatory bowel disorders, autism spectrum disorders, and in multiple sclerosis.

Nectid's founder/CEO Ram Sesha has said, "This is a repurposing program of a known drug to provide several key unmet needs. Sleep and fatigue are significant issues in chronic pain and multiple sclerosis, etc.  Similarly, sleep difficulties particularly insomnia, occur in 50–80% of children with autism spectrum disorders and tend to affect day time behavior. In our proof of concept studies, Agomelatine was found effective in reducing neuropathic pain, pain from fibromyalgia, and in improving sleep and day time behavior in children with Autism Spectrum Disorders. The data, to be released soon, was found statistically significant in all three cases. Nectid plans to develop these projects through FDA approval while in licensing discussion with multiple interested parties." 

About Nectid

Nectid, (www.nectid.com), is a Princeton based drug-discovery company that focuses on repurposing known drugs for Central Nervous System (CNS), developmental and metabolic disorders. Nectid has licensed 21 patents in the last three years to branded pharmaceutical companies. Nectid raised a Series A funding recently from Singapore based Agnus Global Fund. Nectid has three project at clinical stage and six projects at conceptual stage. 


'/>"/>
SOURCE Nectid, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Apexigen Announces the Filing of an IND by its Partner, 3SBio
2. Neuralstem Announces Exercise Of Entire Over-Allotment Option By Aegis Capital Corp.
3. Perrigo Company Announces Quarterly Dividend
4. Trovagene, Inc. Announces Second Quarter and Year to Date Earnings, Provides Milestone Update
5. Cambrex Announces Significant New Supply Agreement
6. Sunpeaks Ventures Announces Second Quarter 2012 Results
7. MultiCell Announces Results of Shareholders Meeting
8. ChemAxon Announces New Version of chemicalize.org for Tablet PCs
9. Naturs Design Announces the Dreams With Hope Tour, a Nationwide Sleep Awareness Campaign
10. ADVENTRX Announces Appointment Of Chief Medical Officer
11. FDAnews Announces Medical Device Mobile Apps Virtual Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... CLEMENTE, Calif. , June 24, 2016  American Respiratory Labs ... company, is now able to perform sophisticated lung assessments in patients, ... Technologies , Inc. Patients are no longer limited ... ndd,s EasyOne PRO ® , ARL patients like Jeanne R. of ... done in the comfort of her own home. ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
Breaking Medicine News(10 mins):